Please login to the form below

Not currently logged in
Email:
Password:

Wellcome Trust director Sir Mark Walport named UK’s chief scientific adviser

Will provide scientific advice direct to Prime Minister David Cameron and the cabinet

The director of research charity the Wellcome Trust Sir Mark Walport has been appointed chief scientific adviser to the UK government.

Taking up his new post in April, 2013, Sir Mark will replace Sir John Beddington in providing advice directly to Prime Minister David Cameron and the cabinet concerning scientific issues.

“Science, engineering and technology have transformed the infrastructure of the modern world, and have a vital role to play at the heart of policy making,” said Sir Mark.

"They are critical both to economic recovery and growth, and to addressing many of the greatest challenges of our time, such as environmental change and the ageing population.”

With a background in immunology, Sir Mark will play a key role in the implementation of the £180m worth of life sciences reforms in the UK announced by Cameron at the end of 2011.

He will also work with ministers, the scientific community and the media to ensure that scientific methods, risk and uncertainty are understood by the public.

Sir Mark had been director of the Wellcome Trust since 2003, leading the body in its support of scientific and medical research.

This included studies into the human genome and human brain, infectious diseases such as malaria and MRSA, and chronic diseases such as diabetes and cancer.

The Trust's chair Sir Bill Castell is to lead the board of governors in the recruitment of a new director.

He said: "Mark has led the Wellcome Trust with great distinction over a decade of extraordinary achievement, and there is nobody in Britain better placed to ensure that science plays the central role it deserves to in public policy. British science will be stronger for his appointment.”

5th July 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Anthill is a specialist digital agency and a strategic partner for life science companies....

Latest intelligence

Devil_in_the_edetail.png
The Devil is in the E-Detail
All too often, pharma companies are relying on the e-detailing approach, and missing a big opportunity to engage with their customers, build relationships, and add value....
Medical Translations: Why you need to get it right the first time
British and American senior medical executives admit to image and reputation being at risk because of misinterpreted cultural references or linguistic errors....
Digital disruption
How pharma is keeping up with the pace of change...

Infographics